Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Current Opinion in Oncology|July 20, 2002
Update on pancreatic cancerCaio Max S Rocha Lima, Barbara CentenoSeminars in Oncology|July 15, 2005
Docetaxel in the management of advanced pancreatic cancerGilberto Lopes, Caio Max S Rocha LimaOncology (Williston Park, N.Y.)|October 12, 2002
Topoisomerase I-based nonplatinum combinations in non-small-cell lung cancerCaio Max S Rocha Lima, Marcos G JoppertCurrent Treatment Options in Oncology|December 14, 2005
Management of small cell lung cancerKristen Keon Ciombor, Caio Max S Rocha LimaCancer|January 30, 2002
Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group BCaio Max S Rocha Lima, James E Herndon, Michael Kosty, et al.Medical Oncology (Northwood, London, England)|October 29, 2011
Preoperative docetaxel/cisplatin/5-fluorouracil chemotherapy in patients with locally advanced gastro-esophageal adenocarcinomaUlas Darda Bayraktar, Soley Bayraktar, Peter Hosein, et al.Cancer|September 20, 2013
Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma?Ulas Darda Bayraktar, Emerson Chen, Soley Bayraktar, et al.British Journal of Cancer|June 21, 2017
Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatmentRichard Kim, E Gabriela Chiorean, Manik Amin, et al.Journal of Surgical Oncology|June 21, 2023
Comparison of survival for metastatic pancreatic cancer patients treated with CPI-613 versus resected borderline-resectable pancreatic cancer patientsChristopher W Mangieri, Cristian D Valenzuela, Ian B Solsky, et al.Investigational New Drugs|June 12, 2014
A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumorsJames M Cleary, Caio Max S Rocha Lima, Herbert I Hurwitz, et al.Pageof 2